SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 2413.64 millions rose by 39.72% from Rs. 1727.48 millions.The Net proft of the company remain more or less same to Rs. 252.87  millions from Rs. 256.22 millions ,decline by -1.31%.OP of the company witnessed a marginal growth to 433.00 millions from 395.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2413.64 1727.48 39.72 6280.78 5021.59 25.08 6552.04 6582.89 -0.47
Other Income 13.25 157.14 -91.57 498.79 561.80 -11.22 604.82 422.51 43.15
PBIDT 433.00 395.30 9.54 1559.11 1253.74 24.36 1523.85 1559.66 -2.30
Interest 2.67 8.48 -68.51 7.60 29.56 -74.29 36.13 37.95 -4.80
PBDT 430.33 386.82 11.25 1551.51 1224.18 26.74 1487.72 1521.71 -2.23
Depreciation 84.34 41.79 101.82 216.56 132.27 63.73 167.37 176.63 -5.24
PBT 345.99 345.03 0.28 1334.95 1091.91 22.26 1320.35 1345.08 -1.84
TAX 93.12 88.81 4.85 327.28 241.34 35.61 291.69 305.20 -4.43
Deferred Tax -4.44 1.56 -384.62 37.86 2.50 1414.40 -1.71 5.04 -133.93
PAT 252.87 256.22 -1.31 1007.67 850.57 18.47 1028.66 1039.88 -1.08
Equity 453.16 402.96 12.46 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 17.94 22.88 -21.60 24.82 24.97 -0.57 23.26 23.69 -1.84

Marksans Pharma Share Price

193.05 13.45 (7.49%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×